In a streptozotocin-induced diabetic rat model, Yeh et al. found that ATX administration attenuated diabetes-related ocular nerve injury by upregulating HO-1 to decrease oxidative stress and secondary inflammation and that NF-κB acted downstream following HO-139. The gene discussed is NFKB1; the disease is diabetes mellitus.